This acquisition expands Endpoint into clinical supply planning while keeping Bluefin independent and RTSM-agnostic. RALEIGH, NC, and BOSTON, MA — [September 14, 2026] — Endpoint Clinical L.P., a…
RALEIGH, N.C. – April 13 2026 – Endpoint Clinical today announced the release of Elosity® R3, a major update to its next-generation Randomization and Trial Supply Management (RTSM)…
Endpoint Clinical Named a Leader in Everest Group’s 2025 Life Sciences RTSM Products PEAK Matrix® Assessment RALEIGH, N.C.– December 1, 2025 – Endpoint Clinical has been recognized…
Endpoint Clinical, a global leader in randomization and trial supply management (RTSM) solutions, today announced a major brand refresh, reflecting the next evolution of Endpoint.
Raleigh, NC – March 20, 2025 – Endpoint Clinical (“Endpoint”), a global leader in randomization and trial supply management (“RTSM”) solutions and a portfolio company of Arsenal Capital…
